| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/13/2003 | CA2458879A1 Genetic construct intracellular monitoring system |
| 03/13/2003 | CA2458876A1 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
| 03/13/2003 | CA2458799A1 Treatment for central nervous system disorders |
| 03/13/2003 | CA2458786A1 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof |
| 03/13/2003 | CA2458677A1 Methods and compositions for treating inflammatory disorders |
| 03/13/2003 | CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 03/13/2003 | CA2458357A1 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight |
| 03/13/2003 | CA2458237A1 Vaccine therapies and prophylactic treatments of atherosclerotic diseases |
| 03/13/2003 | CA2457520A1 Modified transferrin fusion proteins |
| 03/13/2003 | CA2457429A1 Modified factor ix |
| 03/12/2003 | EP1291433A1 Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds |
| 03/12/2003 | EP1291432A1 Novel promoters and gene expression method by using the promoters |
| 03/12/2003 | EP1291425A2 Human Na+/H+ exchanger protein and uses thereof |
| 03/12/2003 | EP1291424A1 Gasc1 gene |
| 03/12/2003 | EP1291423A1 Polyfunctional base sequence and artificial gene containing the same |
| 03/12/2003 | EP1291422A2 Human nucleic acid from ovarian tumor tissue |
| 03/12/2003 | EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 03/12/2003 | EP1291359A1 Amino acid sequence motifs characteristic of GPCR subfamilies, and methods for GPCR characterization |
| 03/12/2003 | EP1291358A1 Feline hepatocyte growth factor |
| 03/12/2003 | EP1291357A2 Recombinant protein materials which bind with anti-hcmv antibodies |
| 03/12/2003 | EP1290449A1 Use of the g protein coupled receptor gpr3 to identify apetite control agents |
| 03/12/2003 | EP1290230A2 Hepatitis c virus conjugates |
| 03/12/2003 | EP1290217A2 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| 03/12/2003 | EP1290216A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells |
| 03/12/2003 | EP1290206A2 Recombinant aav vectors for gene therapy of obesity |
| 03/12/2003 | EP1290203A2 Modulation of abscisic acid signal transduction in plants |
| 03/12/2003 | EP1290202A1 A novel plant cyclin |
| 03/12/2003 | EP1290201A2 Recombinant subunit proteins from porcine parvovirus produced in plants |
| 03/12/2003 | EP1290200A1 Protein translocation into plant cells |
| 03/12/2003 | EP1290196A1 Chimeric hsf transcription factors |
| 03/12/2003 | EP1290194A1 Production of secreted polypeptides |
| 03/12/2003 | EP1290191A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/12/2003 | EP1290179A2 Method for isolating and using fungal hemolysin |
| 03/12/2003 | EP1290178A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 03/12/2003 | EP1290177A1 Bartonella henselae virb operon and proteins encoded thereby |
| 03/12/2003 | EP1290175A1 Scramblase 2 |
| 03/12/2003 | EP1290174A2 G-protein coupled receptor org3. |
| 03/12/2003 | EP1290173A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwk1) |
| 03/12/2003 | EP1290172A2 Regulation of human isotocin-like g protein-coupled receptor |
| 03/12/2003 | EP1290171A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/12/2003 | EP1290170A2 Binding agents: chimeric ligand/receptor proteins |
| 03/12/2003 | EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 03/12/2003 | EP1290168A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/12/2003 | EP1290167A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 03/12/2003 | EP1290166A1 Mutation in the beta 2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy |
| 03/12/2003 | EP1290165A2 Heteromultimeric ion channel receptor and uses thereof |
| 03/12/2003 | EP1290164A2 Human twik molecules and uses thereof |
| 03/12/2003 | EP1290163A2 Regulation of human serotonin-like g protein-coupled receptor |
| 03/12/2003 | EP1290162A2 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 03/12/2003 | EP1290160A2 Human pellino polypeptides |
| 03/12/2003 | EP1290153A2 Molecular delivery vehicle for delivery of selected compounds to targets |
| 03/12/2003 | EP1290152A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/12/2003 | EP1290151A1 Novel motor proteins and methods for their use |
| 03/12/2003 | EP1290142A1 Short-root gene, promoter, and uses thereof |
| 03/12/2003 | EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 03/12/2003 | EP1290137A2 Virulence genes, proteins, and their use |
| 03/12/2003 | EP1290030A2 Regulation of human lgr4-like g protein-coupled receptor |
| 03/12/2003 | EP1290029A2 Compositions comprising net-4 modulators and their use for treating neoplastic disease |
| 03/12/2003 | EP1290028A2 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 03/12/2003 | EP1290027A2 Immunoadhesin for the prevention of rhinovirus infection |
| 03/12/2003 | EP1290026A2 Human sez6 nucleic acids and polypeptides |
| 03/12/2003 | EP1290025A2 REGULATION OF HUMAN GluR5-LIKE RECEPTOR |
| 03/12/2003 | EP1290024A1 Glucose dependent release of insulin from glucose sensing insulin derivatives |
| 03/12/2003 | EP1290023A2 Nuclear factor kb inducing factor |
| 03/12/2003 | EP1290022A1 Tyrosine kinase modulators |
| 03/12/2003 | EP1290021A2 Polynucleotide sequence encoding a putative cell adhesion molecule |
| 03/12/2003 | EP1290020A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 03/12/2003 | EP1290019A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 03/12/2003 | EP1290018A2 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus |
| 03/12/2003 | EP1290017A2 Compositions and methods for delivery of a molecule into a cell |
| 03/12/2003 | EP1290016A2 Vaccine for congenital tremors in pigs |
| 03/12/2003 | EP1290015A2 Epididymis-specific proteins with fibronectin type ii modules |
| 03/12/2003 | EP1290014A2 Structure of g-protein (rgs4) and methods of identifying agonists and antagonists using same |
| 03/12/2003 | EP1290013A2 Apo-ai/aii peptide derivatives |
| 03/12/2003 | EP1290009A1 Plant promoter |
| 03/12/2003 | EP1290008A1 Colon carcinoma related polynucleotides |
| 03/12/2003 | EP1290007A2 Secreted proteins and polynucleotides encoding them |
| 03/12/2003 | EP1290005A2 Vegf-modulated genes and methods employing them |
| 03/12/2003 | EP1290004A1 Method of identifying critical points within protein-protein interactions |
| 03/12/2003 | EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof |
| 03/12/2003 | EP1289553A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 03/12/2003 | EP1289549A2 The use of plant oil-bodies in vaccine delivery systems |
| 03/12/2003 | EP1289547A2 Immunization through oral administration of a vaccine with an edible product |
| 03/12/2003 | EP1289545A1 Snthetic vaccine for tick control |
| 03/12/2003 | EP1289541A2 Interferon for the treatment of multiple sclerosis |
| 03/12/2003 | EP1223967A4 Fc GAMMA RIA |
| 03/12/2003 | EP1222199A4 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 03/12/2003 | EP1187848A4 Annexin derivatives with endogenous chelation sites |
| 03/12/2003 | EP1169483A4 VARIATION IN DRUG RESPONSE RELATED TO POLYMORPHISMS IN $g(b) 2?- ADRENERGIC RECEPTOR |
| 03/12/2003 | EP1002080B1 Fluorescent proteins as cell-type specific reporter |
| 03/12/2003 | EP0946191B1 Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity |
| 03/12/2003 | EP0895478B1 Component b as cicatrizant |
| 03/12/2003 | EP0871757B1 Conditionally replicating viral vectors and their use |
| 03/12/2003 | EP0866870B1 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS |
| 03/12/2003 | EP0850311B1 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants |
| 03/12/2003 | EP0831881B1 Cetp for increasing hdl cholesterol level |
| 03/12/2003 | EP0821742B1 Phycobilisomes, derivatives, and uses therefor |
| 03/12/2003 | EP0811067B1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 03/12/2003 | EP0789577B1 Synthesis of n-substituted oligomers |
| 03/12/2003 | EP0787016B1 Secretory leukocyte protease inhibitor (slpi) as an inhibitor of tryptase |